EUVIMEDEUVIMED entdecken
Crossref

Hounsfield Units Predict Survival of Patients With Estrogen Receptor-Positive and Human Epithelial Growth Factor Receptor 2-Negative Breast Cancer

Seung Taek Lim, Hyang Suk Choi, Kwangmin Kim, Seok Hahn, In-Jeong Cho, Hany Noh, Jong-In Lee, Airi Han

Clinical Breast Cancer · 2023

DOI: 10.1016/j.clbc.2023.06.012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Breast Cancer, 2023. Verfasst von Seung Taek Lim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Yonsei University Wonju College of Medicine, Wonju, Korea. Hauptthemen laut MEDLINE: Receptors, Estrogen, Erb-b2 Receptor Tyrosine Kinases, Breast Neoplasms. Die Arbeit nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUNDS: Tumor vascularity plays a fundamental role in cancer progression, including breast cancer. This study aimed to elucidate tumor vascularity and its impact on patient survival in the context of breast cancer subtypes using Hounsfield units (HU) on contrast-enhanced computed tomography (CT). MATERIALS AND METHODS: Patients with early-stage breast cancer who completed planned treatment between 2003 and 2013 were retrospectively assessed. RESULTS: The final cohort comprised 440 patients. Of the 440 patients, 262 had estrogen receptor (ER)-positive disease and 119 had human epidermal growth factor receptor 2 (HER2)-overexpressing disease. The tumor-to-aorta ratio of Hounsfield units (TAR) was related to significantly worse recurrence-free interval (RFI) (P 0.33 for RFI and > 0.35 for OS than their counterparts. In the subgroup analysis, the survival disadvantage was limited only to patients with ER-positive and HER2-negative disease (P < .001 for both RFI and OS). CONCLUSION: This study showed that TAR, which reflects tumor vascularity, was significantly related to patients' RFI and OS, suggesting its capacity as a feasible biomarker. This study also showed that TAR was associated with the survival in patients with ER-positive and HER2-negative disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, EstrogenErb-b2 Receptor Tyrosine KinasesBreast NeoplasmsHumansFemaleMiddle AgedRetrospective StudiesAdultAgedPrognosisTomography, X-Ray ComputedAged, 80 and overBiomarkers, TumorFollow-Up Studies

Stichwörter der Autor:innen

Breast neoplasmsSubtypeVascularity

Substanzen

Receptors, EstrogenErb-b2 Receptor Tyrosine KinasesERBB2 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Oncology, Yonsei University Wonju College of Medicine, Wonju, Korea.
  • Department of Surgery, Yonsei University Wonju College of Medicine, Wonju, Korea.
  • Department of Radiology, Inje University College of Medicine, Haeundae Paik Hospital, Busan, Korea.
  • Department of Surgery, Yonsei University Wonju College of Medicine, Wonju, Korea. Electronic address: airihan@yonsei.ac.kr.

Zitieren

APA

Lim, S. T., Choi, H. S., Kim, K., Hahn, S., Cho, I. J., Noh, H., Lee, J. I., & Han, A. (2023). Hounsfield Units Predict Survival of Patients With Estrogen Receptor-Positive and Human Epithelial Growth Factor Receptor 2-Negative Breast Cancer. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2023.06.012

Vancouver

Lim ST, Choi HS, Kim K, Hahn S, Cho IJ, Noh H, et al. Hounsfield Units Predict Survival of Patients With Estrogen Receptor-Positive and Human Epithelial Growth Factor Receptor 2-Negative Breast Cancer. Clinical Breast Cancer. 2023. doi:10.1016/j.clbc.2023.06.012

BibTeX
@article{Lim2023,
  author = {Lim, Seung Taek and Choi, Hyang Suk and Kim, Kwangmin and Hahn, Seok and Cho, In-Jeong and Noh, Hany and Lee, Jong-In and Han, Airi},
  title = {Hounsfield Units Predict Survival of Patients With Estrogen Receptor-Positive and Human Epithelial Growth Factor Receptor 2-Negative Breast Cancer},
  journal = {Clinical Breast Cancer},
  year = {2023},
  doi = {10.1016/j.clbc.2023.06.012}
}
Kostenlos starten →